Ling-xiu Fan

No ORCID on file · 5 papers in corpus · active 2021-2024

Study types

  • review 3
  • article 2

Condition tags

  • dysmenorrhea 3
  • adenomyosis 3
  • endometriosis 2
review 2024
Analysis of related factors influencing postoperative recurrence of adenomyosis treated with HIFU
Archives of gynecology and obstetrics ·doi:10.1007/s00404-023-07340-x

OBJECTIVE: To analyze the efficacy of high-intensity focused ultrasound (HIFU) for adenomyosis and postoperative recurrence and its influencing factors. METHODS: Clinical and follow-up data of 308 patients with adenomyosis who were treated…

article 2023
β-Sitosterol Inhibits The Proliferation of Endometrial Cells via Regulating Smad7-Mediated TGF-β/Smads Signaling Pathway.
Cell journal ·doi:10.22074/cellj.2023.1989631.1230

OBJECTIVE: To investigate the effect of β-sitosterol on endometrial cells to understand the underlying mechanism. MATERIALS AND METHODS: This is a laboratory-based experimental study conducted on animals and cells. Histological assays were …

review 2022
Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis
Archives of gynecology and obstetrics ·doi:10.1007/s00404-022-06720-z
article 2022
NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2022.2162495

BACKGROUND: NeiyiKangfu tablets (NYKF) are widely used clinically for the treatment of endometriosis (EMS), whose mechanism of action has been extensively studied. Researchers have found that NYKF may control the development of ectopic lesi…

review 2021
Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis
Frontiers in public health ·doi:10.3389/fpubh.2021.688264

Objective: High-intensity focused ultrasound (HIFU) is an innovative non-invasive technology used for adenomyosis. Gonadotropin-releasing hormone agonist (GnRH-a) is a hormone commonly used for adenomyosis. We investigated and assessed the …